Abstract
Oral nonodontogenic masses in children, while frequently reported as individual cases, lack comprehensive large-scale clinical analysis. This retrospective study of 171 pediatric patients treated between 2014 and 2019 explores the clinical characteristics, prevalence, and management of these lesions. The findings indicate that the vast majority of these masses are benign, with vascular anomalies being the most prevalent. Surgical resection remains the primary treatment modality, yielding high success rates.
Introduction
In pediatric clinical practice, oral masses often trigger significant parental concern. While "odontogenic" tumors—those arising from tissues that form teeth—are well-documented, "nonodontogenic" masses are less frequently studied in large cohorts. These lesions can grow rapidly, potentially leading to airway obstruction or feeding difficulties. This study aims to fill the data gap by providing a comprehensive overview of the clinical features and treatment outcomes for nonodontogenic oral masses in children.
Methods and Patient Cohort
Researchers at the Children’s Hospital of Nanjing Medical University conducted a retrospective observational study of 171 patients treated over a five-year period (2014–2019). The cohort included children aged 0 to 14 years, with a mean age of 2.9 years. Data points collected included patient demographics, anatomical site of the lesion, pathologic diagnosis, and the specific treatment strategies employed.
Results
Prevalence and Demographics
The study identified a strong prevalence of vascular anomalies, which accounted for 83% of all cases. Hemangiomas were the most common diagnosis (63.7%), followed by lymphangiomas (16.4%) and ranulas (7.6%). Interestingly, the data revealed distinct gender trends: hemangiomas were more frequent in females (1:1.7 ratio), while lymphangiomas and ranulas showed a higher incidence in males.
Anatomical Distribution
The anatomical location of the masses varied significantly. The tongue was the most frequent site, accounting for 44.7% of cases, followed by the buccal mucosa at 23.4%. Notably, a significant portion of hemangioma patients (26.6%) and lymphangioma patients (39.3%) presented with additional extraoral lesions, necessitating thorough physical examinations beyond the oral cavity.
Treatment Outcomes and Recurrence
Surgical resection was the primary treatment for most benign tumors, such as teratomas and hamartomas. For hemangiomas, a more conservative approach involving propranolol and sclerotherapy has become common, reducing the need for invasive surgery. The study noted a recurrence rate of 17.9% for lymphangiomas and 8.3% for hemangiomas, highlighting the challenge of completely eradicating vascular lesions.
Clinical Insights
- Vascular Dominance: The high incidence of vascular anomalies suggests that clinicians should prioritize vascular origins in their differential diagnosis for pediatric oral masses.
- Early Presentation: Over 90% of patients were under 7 years old, emphasizing the need for vigilant screening during early childhood.
- Malignant Mimicry: Although 170 cases were benign, one instance of Inflammatory Myofibroblastic Tumor (IMT) displayed malignant behavior. This underscores that even histologically "benign" lesions can require aggressive management.
Conclusion
Most oral nonodontogenic masses in children are benign and can be successfully managed through surgical or pharmacological means. However, the potential for recurrence in vascular anomalies and the rare occurrence of aggressive tumors like IMT necessitate individualized treatment plans and long-term follow-up. Future research should focus on targeted therapies for rare, aggressive lesions to further improve pediatric outcomes.
Summary updated